Fulminant Hepatitis B as a Result of Reactivation in Hematologic Patient After Rituximab Therapy

dc.contributor.authorYilmaz, Bulent
dc.date.accessioned2020-03-26T19:24:20Z
dc.date.available2020-03-26T19:24:20Z
dc.date.issued2016
dc.departmentSelçuk Üniversitesien_US
dc.description.abstract[Abstract not Available]en_US
dc.identifier.doi10.1002/jmv.24476en_US
dc.identifier.endpage1290en_US
dc.identifier.issn0146-6615en_US
dc.identifier.issn1096-9071en_US
dc.identifier.issue8en_US
dc.identifier.pmid27249067en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1289en_US
dc.identifier.urihttps://dx.doi.org/10.1002/jmv.24476
dc.identifier.urihttps://hdl.handle.net/20.500.12395/33631
dc.identifier.volume88en_US
dc.identifier.wosWOS:000383669500001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWILEY-BLACKWELLen_US
dc.relation.ispartofJOURNAL OF MEDICAL VIROLOGYen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleFulminant Hepatitis B as a Result of Reactivation in Hematologic Patient After Rituximab Therapyen_US
dc.typeLetteren_US

Dosyalar